Cargando…

Comparison between ticagrelor and clopidogrel in myocardial infarction patients with high bleeding risk

AIMS: Ticagrelor is associated with a lower risk of ischemic events than clopidogrel. However, it is uncertain whether the benefits of more intensive anti-ischemic therapy outweigh the risks of major bleeding in patients who have a high bleeding risk (HBR). Therefore, this study compared ticagrelor...

Descripción completa

Detalles Bibliográficos
Autores principales:	Tjerkaski, Jonathan, Jernberg, Tomas, Alfredsson, Joakim, Erlinge, David, James, Stefan, Lindahl, Bertil, Mohammad, Moman Aladdin, Omerovic, Elmir, Venetsanos, Dimitrios, Szummer, Karolina
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Oxford University Press 2023
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10627816/ https://www.ncbi.nlm.nih.gov/pubmed/37263787 http://dx.doi.org/10.1093/ehjcvp/pvad041

Ejemplares similares

Bleeding complications with clopidogrel or ticagrelor in ST-elevation myocardial infarction patients – A real life cohort study of two treatment strategies()
por: Alfredsson, Joakim, et al.
Publicado: (2020)

Association of Ischemic and Bleeding Events With Mortality Among Patients in Sweden With Recent Acute Myocardial Infarction Receiving Antithrombotic Therapy
por: Simonsson, Moa, et al.
Publicado: (2022)

Improved outcomes in patients with ST-elevation myocardial infarction during the last 20 years are related to implementation of evidence-based treatments: experiences from the SWEDEHEART registry 1995–2014
por: Szummer, Karolina, et al.
Publicado: (2017)

Circadian onset and prognosis of myocardial infarction with non-obstructive coronary arteries (MINOCA)
por: Nordenskjöld, Anna M., et al.
Publicado: (2019)

Prevalence and prognostic impact of left ventricular systolic dysfunction or pulmonary congestion after acute myocardial infarction
por: Hamilton, Eleonora, et al.
Publicado: (2023)

Sex Differences in Treatments, Relative Survival, and Excess Mortality Following Acute Myocardial Infarction: National Cohort Study Using the SWEDEHEART Registry
por: Alabas, Oras A, et al.
Publicado: (2017)

Development and Validation of a Novel Risk Score for In‐Hospital Major Bleeding in Acute Myocardial Infarction:—The SWEDEHEART Score
por: Simonsson, Moa, et al.
Publicado: (2019)

Christmas, national holidays, sport events, and time factors as triggers of acute myocardial infarction: SWEDEHEART observational study 1998-2013
por: Mohammad, Moman A, et al.
Publicado: (2018)

Incidence and outcome of myocardial infarction treated with percutaneous coronary intervention during COVID-19 pandemic
por: Mohammad, Moman A, et al.
Publicado: (2020)

Patient-oriented risk score for predicting death 1 year after myocardial infarction: the SweDen risk score
por: Rylance, Rebecca Tremain, et al.
Publicado: (2022)

Ticagrelor versus clopidogrel in the management of acute myocardial infarction
por: Volney, Candice, et al.
Publicado: (2019)

Temporal trends in characteristics and outcome of heart failure patients with and without significant coronary artery disease
por: Bollano, Entela, et al.
Publicado: (2022)

Avoiding Routine Oxygen Therapy in Patients With Myocardial Infarction Saves Significant Expenditure for the Health Care System—Insights From the Randomized DETO2X-AMI Trial
por: Hofmann, Robin, et al.
Publicado: (2022)

Adherence to beta‐blockers and long‐term risk of heart failure and mortality after a myocardial infarction
por: Desta, Liyew, et al.
Publicado: (2020)

Comparing Effect Estimates in Randomized Trials and Observational Studies From the Same Population: An Application to Percutaneous Coronary Intervention
por: Matthews, Anthony A., et al.
Publicado: (2021)

Effects of Ticagrelor and Clopidogrel on Coronary Microcirculation in Patients with Acute Myocardial Infarction
por: Scanavini-Filho, Marco Antonio, et al.
Publicado: (2022)

Ticagrelor versus clopidogrel for recurrent myocardial infarction: An outcomes-based agreement
por: Peasah, Samuel K., et al.
Publicado: (2023)

Aspirin/clopidogrel/ticagrelor: Diffuse ooze and bleeding: 2 case reports
Publicado: (2021)

Interphysician agreement on subclassification of myocardial infarction
por: Gard, Anton, et al.
Publicado: (2018)

Impact of chronic obstructive pulmonary disease on morbidity and mortality after myocardial infarction
por: Andell, Pontus, et al.
Publicado: (2014)

Impact of Baseline Anemia in Patients With Acute Coronary Syndromes Undergoing Percutaneous Coronary Intervention: A Prespecified Analysis From the VALIDATE‐SWEDEHEART Trial
por: Wester, Axel, et al.
Publicado: (2019)

Routine Oxygen Therapy Does Not Improve Health-Related Quality of Life in Patients With Acute Myocardial Infarction—Insights From the Randomized DETO2X-AMI Trial
por: Hofmann, Robin, et al.
Publicado: (2021)

Ticagrelor is Not Superior to Clopidogrel in Patients With Acute Coronary Syndromes Undergoing PCI: A Report from Swedish Coronary Angiography and Angioplasty Registry
por: Völz, Sebastian, et al.
Publicado: (2020)

Differential modulation of polyunsaturated fatty acids in patients with myocardial infarction treated with ticagrelor or clopidogrel
por: Samman, Karla N., et al.
Publicado: (2021)

Design and rationale of randomized evaluation of decreased usage of beta-blockers after acute myocardial infarction (REDUCE-AMI)
por: Yndigegn, Troels, et al.
Publicado: (2022)

On the Natural History of Coronary Artery Disease: A Longitudinal Nationwide Serial Angiography Study
por: Mohammad, Moman A., et al.
Publicado: (2022)

PCI or CABG for left main coronary artery disease: the SWEDEHEART registry
por: Persson, Jonas, et al.
Publicado: (2023)

Efficacy and Safety of Ticagrelor in Comparison to Clopidogrel in Elderly Patients With ST‐Segment–Elevation Myocardial Infarctions
por: Schmucker, Johannes, et al.
Publicado: (2019)

Efficacy and safety of ticagrelor versus clopidogrel in patients with non-ST-elevation myocardial infarction in Taiwan
por: Lee, Chih-Kuo, et al.
Publicado: (2021)

Association between gender and short-term outcome in patients with ST elevation myocardial infraction participating in the international, prospective, randomised Administration of Ticagrelor in the catheterisation Laboratory or in the Ambulance for New ST elevation myocardial Infarction to open the Coronary artery (ATLANTIC) trial: a prespecified analysis
por: Venetsanos, Dimitrios, et al.
Publicado: (2017)

No Differences in Gastrointestinal Bleeding Risk among Clopidogrel-, Ticagrelor-, or Prasugrel-Based Dual Antiplatelet Therapy
por: Laredo, Viviana, et al.
Publicado: (2020)

Association Between Mineralocorticoid Receptor Antagonist Use and Outcome in Myocardial Infarction Patients With Heart Failure
por: Löfman, Ida, et al.
Publicado: (2018)

Combined association of key risk factors on ischaemic outcomes and bleeding in patients with myocardial infarction
por: Lindholm, Daniel, et al.
Publicado: (2019)

Ticagrelor as an Alternative for Clopidogrel-Associated Acute Arthritis
por: Bedy, Starr-Mar'ee C., et al.
Publicado: (2018)

Sex-differences in circulating biomarkers during acute myocardial infarction: An analysis from the SWEDEHEART registry
por: Eggers, Kai M., et al.
Publicado: (2021)

Ticagrelor attenuates the increase of extracellular vesicle concentrations in plasma after acute myocardial infarction compared to clopidogrel
por: Gasecka, Aleksandra, et al.
Publicado: (2020)

Hospitalization for Myocardial Infarction with Ticagrelor or Clopidogrel in Patients with Acute Coronary Syndrome: An On-Treatment Comparative Effectiveness Analysis
por: Olufade, Tope, et al.
Publicado: (2021)

Comparison of the Infarct Size between the Loading of Ticagrelor and Clopidogrel in Patients with Acute Myocardial Infarction Undergoing Primary Percutaneous Coronary Intervention
por: Yun, Kyeong Ho, et al.
Publicado: (2017)

Comparative study of ticagrelor and clopidogrel in therapeutic effect of acute myocardial infarction patients undergoing percutaneous coronary intervention
por: Yao, Guangtao, et al.
Publicado: (2017)

Ticagrelor or clopidogrel dual antiplatelet therapy following a pharmacoinvasive strategy in ST‐segment elevation myocardial infarction
por: Welsh, Robert C., et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_m9s22lsnn437qgdmlj8s2agrm5